Lymph Node Dissection in Stage IV Gastric Cancer Surgery Shows No Short-Term Adverse Risks
A recent study examining palliative gastrectomy in stage IV gastric cancer patients found that retrieving more lymph nodes did not increase 30-day complication or mortality rates.
🧠AI AnalysisPhoto: Medical Xpress
Key points
- Retrospective study evaluated 855 patients with stage IV gastric cancer undergoing palliative gastrectomy.
- Extended lymph node dissection was not linked to higher 30-day complication or mortality rates.
- Researchers cautioned that observational data do not prove a direct therapeutic benefit from removing more nodes.
A recent clinical investigation led by researchers Jae-Seok Min of Korea University Anam Hospital and Sang-Ho Jeong of Gyeongsang National University Changwon Hospital explored whether removing a greater number of lymph nodes affects short-term recovery following palliative gastrectomy for stage IV gastric cancer. Published in the World Journal of Surgery, the retrospective evaluation analyzed data from 855 individuals identified through nationwide registries maintained by the Korean Gastric Cancer Association.
While standard management for advanced stage IV gastric cancer primarily relies on systemic anticancer therapy, palliative surgical intervention is sometimes performed to alleviate specific symptoms such as bleeding or obstruction. Traditionally, surgeons have often limited lymph node removal under the assumption that a less extensive procedure minimizes surgical risks. However, the new registry analysis found that patients who underwent extended lymph node dissection—defined as retrieving 15 or more nodes—did not experience higher 30-day rates of adverse events or mortality compared to those in the limited-dissection group.
To account for underlying patient differences, the research team utilized propensity score weighting, adjusting for variables such as age, overall health status, comorbidities, and surgical approach. Following adjustment, extended dissection remained linked to lower unadjusted rates of complications and mortality, largely because patients selected for limited dissection tended to have poorer baseline health and frailty. The study authors explicitly cautioned that these observational findings do not prove that more extensive dissection provides a therapeutic benefit or actively improves surgical safety.
What to know: The retrospective findings challenge long-held assumptions regarding surgical limits in advanced cancer care, though patients should consult their medical team for personalized treatment decisions.
Specific complications, including pneumonia and leaks, were analyzed descriptively, but researchers emphasized that the data cannot establish a direct causal link between the extent of dissection and specific adverse events. Residual confounding factors, such as individual nutritional status and hidden disease burdens, likely influenced surgical choices and outcomes. The investigators underscored that their work simply questions the notion that restricting lymph node removal inherently makes palliative surgery safer for advanced gastric cancer patients.
Source Medical Xpress — medicalxpress.com/news/2026-11-lymph-node-palliative-gastrectomy-stage.… ↗
Read next
🔬ResearchJAK Inhibitor Shows Potential in Managing Immune Dysregulation in Down Syndrome
A phase 2 clinical trial indicates that the medication tofacitinib can safely reduce chronic immune overactivity in individuals with Down syndrome, leading to improvement…
🏃FitnessUnderstanding and Addressing Love Handles Through Lifestyle Changes
Experts clarify that spot reduction of fat is not physiologically possible, recommending a combination of calorie management and high-intensity interval training instead.
🏃FitnessCiele Releases New Woolmark-Certified Merino Winter Running Apparel
Montreal-based brand Ciele has launched its second collection of merino wool running gear, featuring performance-focused fabrics designed for cold-weather training.
🏥Public HealthPreventive Services Task Force Resumes Meetings Under New Leadership
The U.S. Preventive Services Task Force is set to reconvene this week for the first time in over a year following a significant membership overhaul by Health Secretary Ro…
❤️Conditions & CareBlood-Based Genetic Signature May Predict CAR T-Cell Therapy Success in Lymphoma
Researchers have identified a specific RNA signature in blood plasma that may help predict how well lymphoma patients respond to CAR T-cell therapy.
🧠Mind & Mental HealthAddressing Body Image and the Reality of Gluteal Anatomy
A personal reflection on the social and psychological impact of body shape, specifically regarding the gluteal region, and the limitations of consumer solutions for perce…